Does One Copy of the Christchurch ApoE Variant Slow Alzheimer’s?
Twelve people heterozygous for this protective variant were still sharp seven years after their expected age of AD onset. One had fewer tangles than expected.
120 RESULTS
Sort By:
Twelve people heterozygous for this protective variant were still sharp seven years after their expected age of AD onset. One had fewer tangles than expected.
Invite your friends over, gather loved ones, serve some good munchies, and settle in for a night of TV well worth watching...
Presenilin mutations cause familial Alzheimer disease, but just how they do their damage is not understood...
No eye-popping action scenes, no happy ending...
Public funding is becoming so scarce that the DIAN researchers are increasingly asking industry to help...
The neurodegeneration marker appears to track disease severity in AD and MS patients with great sensitivity.
In familial AD, the faster sTREM2 rises in a person's cerebrospinal fluid, the slower his or her amyloid grows, cortex thins, and cognition fades.
In neurons lacking PS1, late endosomes get bogged down by imbalanced calcium. This puts kinases in a tizzy, slows motor proteins, and makes neurites dystrophic.
Among 1,092 people with PCA, symptoms started around age 60, and 94 percent had amyloid plaques or neurofibrillary tangles.
In mice, these Aβ fibrils avoid riling microglia and astrocytes. They also evade both PiB and lecanemab.
If you follow Alzheimer’s disease research at all, chances are you have heard of the families in the South American nation of Colombia...
In their quest to offer treatment trials to families with autosomal-dominant AD, the scientists driving the DIAN have cleared the next hurdles...
Leaders of DIAN gathered to brief each other to present to some 30 pharmaceutical industry scientists the first cut of baseline data from this ongoing biomarker study...
The striatum does not have a place of notoriety in Alzheimer disease research...
Mutations in amyloid precursor protein and presenilin can give rise to a late-onset, inherited version of Alzheimer’s disease...